Shkreli, the notorious former pharma CEO, made headlines in September 2015 after he raised the pric…

Shkreli is best known for a 2015 price-gouging scandal involving a decades-old drug his c…

The same outside adviser, who was unidentified in Tuesday's release, advised that a package of assi…

On Monday, the judge ordered Shkreli to forfeit $7.36 million in assets, which could include Shkrel…

Shkreli, who was found guilty on two counts of securities fraud, caught the Secret Service's attent…

He caught the country's attention, though, when the company he started after that, Turing, raised t…

The former pharma CEO, who at one point was head of two companies, was arrested in December on char…

Shkreli, 32, was arrested on Thursday morning by federal authorities on charges of securities fraud…

Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…

Earlier this month, Shkreli and KaloBios acquired a drug to treat Chagas disease, a parasitic infec…

"It's a business, we're supposed to make as much money as possible," he said. Shkreli emphasized hi…

Shkreli, a self-professed Trump supporter, first made headlines when a pharmaceutical com…

Shkreli came into the public eye around this time last year when a New York Times report noted that…

To collect the $7.4 million, the government has reportedly suggested it will keep the $5 million Sh…

Shkreli is a known for a 2015 price-gouging scandal involving a decades-old drug his company acquir…

Excerpts from documents obtained by Congress indicate that Shkreli expected the move to increase th…

"When these drugs are priced to reflect more closely their true clinical value, the more accurate p…

In addition to executive departures and a delisting of shares, Marcum LLP resigned as KaloBios' ind…

Mallinckrodt, like most of the other drugmakers, hasn't said much about what its investigation is a…

In other words, consumers deserve a better understanding of what goes into the price of the drug th…